Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20023512HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS20039145HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS20049105HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS20044977HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS20023526HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS20038652HPVENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS44009700HTLV-1ENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS44023101HTLV-1ENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS44049322HTLV-1ENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TVIS44046507HTLV-1ENSG00000165995.24protein_codingCACNB2NoNo783Q08289
TCGA Plot Options
Drug Information
GeneCACNB2
DrugBank IDDB01388
Drug NameMibefradil
Target IDBE0002354
UniProt IDQ08289
Regulation Typeinhibitor
PubMed IDs16899990; 10372226; 10665814
CitationsLee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Epub 2006 Aug 7.@@Mocanu MM, Gadgil S, Yellon DM, Baxter GF: Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Drugs Ther. 1999 Apr;13(2):115-22.@@Jimenez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, Nargeot J: Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels. Neuropharmacology. 2000;39(1):1-10.
GroupsInvestigational; Withdrawn
Direct ClassificationTetralins
SMILESCOCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Pathways
PharmGKBPA450492
ChEMBLCHEMBL45816